课题基金 / 基金详情

Identification of Phosphatase Inhibitors for Host-Directed Tuberculosis Therapy

用于宿主定向结核病治疗的磷酸酶抑制剂的鉴定

批准号：

428946

负责人：

Liang Yi Chu

金额：

$1.27万

依托单位：

University of Ottawa

依托单位国家：

加拿大

项目类别：

Studentship Programs

财政年份：

2019

资助国家：

加拿大

项目状态：

已结题

起止时间：

2019-12-01 至 2020-12-01

来源：

https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=428946&lang=en

关键词：

Antibiotic Resistance Drug Discovery Drug Testing Host-Directed Therapy Immunology Macrophage Microbiology Treatment Tuberculosis

项目摘要

项目成果

相似基金

相关文献

中文摘要

翻译

点击翻译按钮获取中文摘要

英文摘要

"Tuberculosis (TB) is a top 10 cause of death worldwide. It is caused by the Mycobacterium tuberculosis (Mtb) bacteria, which infects immune cells known as macrophages and has developed many ways of resisting antibiotic treatments as well as our immune re

期刊论文(0)

专著(0)

科研奖励(0)

会议论文